Mindbio Therapeutics Corp. (MBIO) Stock Price & Analysis

15 Followers

MBIO Stock Chart & Stats

CA$0.08-CA$0.01(-11.11%)

At close: Nov 09 4:00 PM EST

Day’s Range: CAD 0.08 - CAD 0.08
52-Week Range: CAD 0.08 - CAD 3.99
Previous Close: CAD 0.09
Volume: N/A
Average Volume (3M): 11.78K
Market Cap: CAD 582.64K
Enterprise Value: CAD 11.12M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): CAD 4.57M
Price to Earnings (P/E): ―
Beta: 3.70
Next Earnings: Nov 19, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Mindbio Therapeutics Corp. News

MindBio Hires Venture Liquidity Providers to Support Market Making on CSE

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has engaged Venture Liquidity Providers to act as a market maker for its common shares on the Canadian

7M agoMBIO

MindBio launches Intox Collect to scale AI-driven intoxication detection

An update from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) is now available. MindBio Therapeutics Corp., a biotechnology company specializing in AI-based voice analytics for intoxication detection, has developed Intox Collect,

7M agoMBIO

MindBio Raises $1.44 Million and Launches Marketing Push for Intoxication Detection Tech

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has issued an update. MindBio Therapeutics has closed an upsized non-brokered private placement, raising approximately $1.44 million through the issuance of 2.4 million units

7M agoMBIO

MindBio Boosts Private Placement to $1.5 Million for AI Intoxication Platform

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) just unveiled an announcement. MindBio Therapeutics has increased the size of its previously announced non-brokered private placement from $650,000 to up to $1.5 million,

7M agoMBIO

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

The latest announcement is out from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ). MindBio Therapeutics plans to raise up to $650,000 through a non-brokered private placement of units priced at $0.60,

8M agoMBIO

MindBio taps Chilean policy veteran to drive AI impairment screening push in South American mining

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has appointed Chilean drug and alcohol policy expert and mining safety authority Felipe Leyton to lead commercialization of

8M agoMBIO

MindBio Builds Edge AI Hardware Platform for Voice-Based Intoxication Detection in Mining

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an update. MindBio Therapeutics is moving beyond software-only offerings by developing a proprietary edge computing platform, including dedicated hardware, to run its

8M agoMBIO

MindBio Expands Voice AI Intoxication Screening into South American Mining Sector

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has issued an update. MindBio Therapeutics has deployed a team of software engineers to work with mining and health officials in South America, initially

9M agoMBIO

MindBio Targets Mining Sector With AI Voice-Based Drug and Alcohol Screening Platform

An announcement from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) is now available. MindBio Therapeutics Corp. is advancing commercialization of its AI voice-based drug and alcohol intoxication detection platform by targeting

9M agoMBIO

MindBio Moves Into Global Digital Health Market With AI Voice-Based Intoxication Diagnostics

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has begun targeting the global digital health diagnostics market with its AI-powered speech analytics platform, which uses voice

9M agoMBIO

MBIO FAQ

What was Mindbio Therapeutics Corp.’s price range in the past 12 months?

Mindbio Therapeutics Corp. lowest stock price was C$0.08 and its highest was C$3.99 in the past 12 months.

What is Mindbio Therapeutics Corp.’s market cap?

Mindbio Therapeutics Corp.’s market cap is C$582.64K.

When is Mindbio Therapeutics Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Mindbio Therapeutics Corp.’s earnings last quarter?

Mindbio Therapeutics Corp. released its earnings results on Jun 01, 2026. The company reported -C$0.269 earnings per share for the quarter.

Is Mindbio Therapeutics Corp. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Mindbio Therapeutics Corp. pay dividends?

Mindbio Therapeutics Corp. does not currently pay dividends.

What is Mindbio Therapeutics Corp.’s EPS estimate?

Mindbio Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mindbio Therapeutics Corp. have?

Mindbio Therapeutics Corp. has 7,283,063 shares outstanding.

What happened to Mindbio Therapeutics Corp.’s price movement after its last earnings report?

Mindbio Therapeutics Corp. reported an EPS of -C$0.269 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Mindbio Therapeutics Corp.?

Currently, no hedge funds are holding shares in TSE:MBIO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description